248 related articles for article (PubMed ID: 37552381)
1. Direct Oral Anticoagulants: Navigating Through Clinical Challenges.
Ioannou M; Leonidou E; Chaziri I; Mouzarou A
Cardiovasc Drugs Ther; 2024 Jun; 38(3):637-650. PubMed ID: 37552381
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs).
Hussain SS; Tyroch AH; Mukherjee D
Cardiovasc Hematol Agents Med Chem; 2017; 14(2):76-81. PubMed ID: 27215215
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
Alamneh EA; Chalmers L; Bereznicki LR
Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
[TBL] [Abstract][Full Text] [Related]
4. Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.
Chen A; Stecker E; A Warden B
J Am Heart Assoc; 2020 Jul; 9(13):e017559. PubMed ID: 32538234
[TBL] [Abstract][Full Text] [Related]
5. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant.
Wadsworth D; Sullivan E; Jacky T; Sprague T; Feinman H; Kim J
J Clin Pharm Ther; 2021 Jun; 46(3):560-570. PubMed ID: 33393699
[TBL] [Abstract][Full Text] [Related]
6. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.
Douxfils J; Ageno W; Samama CM; Lessire S; Ten Cate H; Verhamme P; Dogné JM; Mullier F
J Thromb Haemost; 2018 Feb; 16(2):209-219. PubMed ID: 29193737
[TBL] [Abstract][Full Text] [Related]
7. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
8. Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents.
Kaide CG; Gulseth MP
J Emerg Med; 2020 Feb; 58(2):217-233. PubMed ID: 31831187
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Direct Oral Anticoagulants Versus Warfarin for Intracardiac Thromboses.
Iskaros O; Marsh K; Papadopoulos J; Manmadhan A; Ahuja T
J Cardiovasc Pharmacol; 2021 May; 77(5):621-631. PubMed ID: 33560043
[TBL] [Abstract][Full Text] [Related]
10. OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic.
; Curtis HJ; MacKenna B; Walker AJ; Croker R; Mehrkar A; Morton C; Bacon S; Hickman G; Inglesby P; Bates C; Evans D; Ward T; Cockburn J; Davy S; Bhaskaran K; Schultze A; Rentsch CT; Williamson E; Hulme W; Tomlinson L; Mathur R; Drysdale H; Eggo RM; Wong AY; Forbes H; Parry J; Hester F; Harper S; Douglas I; Smeeth L; Goldacre B
Open Heart; 2021 Nov; 8(2):. PubMed ID: 34785588
[TBL] [Abstract][Full Text] [Related]
11. Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?
Papadaki S; Tselepis AD
Angiology; 2019 Nov; 70(10):896-907. PubMed ID: 31010298
[TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban: Expanded Role in Cardiovascular Disease Management-A Literature Review.
Ajmal M; Friedman J; Sipra QUAR; Lassar T
Cardiovasc Ther; 2021; 2021():8886210. PubMed ID: 33505518
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulants (DOACs).
Vazquez S; Rondina MT
Vasc Med; 2015 Dec; 20(6):575-7. PubMed ID: 26285587
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulation in Lung Transplant Recipients.
Hage R; Bonzon J; Schuurmans MM
Exp Clin Transplant; 2024 Apr; 22(4):249-257. PubMed ID: 38742314
[TBL] [Abstract][Full Text] [Related]
16. Drug Treatment of Venous Thromboembolism in the Elderly.
Boey JP; Gallus A
Drugs Aging; 2016 Jul; 33(7):475-90. PubMed ID: 27255713
[TBL] [Abstract][Full Text] [Related]
17. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
[TBL] [Abstract][Full Text] [Related]
18. Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.
Mohammad I; Korkis B; Garwood CL
Pharmacotherapy; 2017 Oct; 37(10):1284-1297. PubMed ID: 28730690
[TBL] [Abstract][Full Text] [Related]
19. Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants.
Ten Cate H; Henskens YM; Lancé MD
Vasc Health Risk Manag; 2017; 13():457-467. PubMed ID: 29263674
[TBL] [Abstract][Full Text] [Related]
20. Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation.
Fatima B; Mohan A; Altaie I; Abughosh S
J Manag Care Spec Pharm; 2024 May; 30(5):408-419. PubMed ID: 38701026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
